Semi-Annual Consolidated Balance Sheet

Daito Pharmaceutical Co., Ltd. - Filing #7289262

Concept As at
2024-11-30
As at
2024-05-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
3,241,000,000 JPY
2,727,000,000 JPY
Other
806,000,000 JPY
1,152,000,000 JPY
Allowance for doubtful accounts
-1,000,000 JPY
-1,000,000 JPY
Current assets
43,601,000,000 JPY
41,460,000,000 JPY
Non-current assets
Property, plant and equipment
31,465,000,000 JPY
31,972,000,000 JPY
Property, plant and equipment
Buildings and structures
Buildings and structures, net
18,406,000,000 JPY
18,291,000,000 JPY
Machinery, equipment and vehicles
Machinery, equipment and vehicles, net
6,426,000,000 JPY
6,343,000,000 JPY
Other
Other, net
6,632,000,000 JPY
7,337,000,000 JPY
Intangible assets
Other
481,000,000 JPY
490,000,000 JPY
Intangible assets
481,000,000 JPY
490,000,000 JPY
Investments and other assets
4,084,000,000 JPY
3,784,000,000 JPY
Investments and other assets
Investment securities
2,110,000,000 JPY
3,188,000,000 JPY
Other
1,983,000,000 JPY
604,000,000 JPY
Allowance for doubtful accounts
-8,000,000 JPY
-8,000,000 JPY
Non-current assets
36,031,000,000 JPY
36,247,000,000 JPY
Assets
79,633,000,000 JPY
77,708,000,000 JPY
Liabilities
Current liabilities
Notes and accounts payable - trade
5,097,000,000 JPY
5,262,000,000 JPY
Income taxes payable
920,000,000 JPY
195,000,000 JPY
Provisions
75,000,000 JPY
58,000,000 JPY
Other
4,095,000,000 JPY
7,452,000,000 JPY
Current liabilities
17,437,000,000 JPY
18,505,000,000 JPY
Non-current liabilities
Long-term borrowings
8,019,000,000 JPY
4,669,000,000 JPY
Provisions
28,000,000 JPY
20,000,000 JPY
Retirement benefit liability
327,000,000 JPY
320,000,000 JPY
Other
1,799,000,000 JPY
1,926,000,000 JPY
Non-current liabilities
10,174,000,000 JPY
6,937,000,000 JPY
Liabilities
27,612,000,000 JPY
25,443,000,000 JPY
Net assets
Shareholders' equity
Share capital
7,186,000,000 JPY
7,186,000,000 JPY
Capital surplus
7,072,000,000 JPY
7,072,000,000 JPY
Retained earnings
36,671,000,000 JPY
37,087,000,000 JPY
Treasury shares
-126,000,000 JPY
-990,000,000 JPY
Shareholders' equity
50,803,000,000 JPY
50,355,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
852,000,000 JPY
1,332,000,000 JPY
Foreign currency translation adjustment
363,000,000 JPY
369,000,000 JPY
Remeasurements of defined benefit plans
-5,000,000 JPY
11,000,000 JPY
Valuation and translation adjustments
1,209,000,000 JPY
1,713,000,000 JPY
Non-controlling interests
7,000,000 JPY
196,000,000 JPY
Net assets
52,020,000,000 JPY
52,265,000,000 JPY
Liabilities and net assets
79,633,000,000 JPY
77,708,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.